Natural Capsules AGM 2026: 6 Resolutions Pass 99.99%

AGM outcome: six resolutions cleared

Natural Capsules Limited has released the final voting results and the scrutinizer’s report for its 33rd Annual General Meeting (AGM), with all six resolutions approved. The AGM was conducted through video conferencing on August 12, 2026. The company’s filing notes that the voting results were declared after receipt of the scrutinizer’s report. Across all resolutions, the support level was near-unanimous, with over 99% votes in favour. The voting pattern also showed the promoter group’s decisive role in determining outcomes. The disclosures were positioned as compliance submissions under applicable regulations.

When and how shareholders voted

The AGM commenced at 12:10 PM and concluded at 1:00 PM, as per the meeting details shared. Natural Capsules provided remote e-voting to shareholders from August 8, 2026 (9:00 AM) to August 11, 2026. An additional voting window was also made available during the virtual AGM. The company’s filings indicate that the process followed regulatory frameworks for electronic participation. The report also states that no invalid votes were recorded for any resolution. For investors, this matters because it confirms procedural compliance and provides a transparent breakdown of how different shareholder categories voted.

Chairing and compliance confirmations

The meeting was chaired by Independent Director Tekkar Yashwanth Prabhu. The scrutinizer’s report confirms compliance with SEBI LODR requirements and provisions of the Companies Act. The company also referenced relevant circulars from the Ministry of Corporate Affairs and the Institute of Company Secretaries of India for conducting meetings through VC/OAVM. These confirmations are typically important for governance-sensitive resolutions, including remuneration changes and related party transactions. The filing emphasised that the voting outcome is backed by the scrutinizer’s formal verification.

What was approved: accounts, directors, pay and RPTs

Shareholders approved adoption of the audited standalone and consolidated financial statements for the year ended March 31, 2026 (FY26). The AGM also cleared reappointments of directors, along with approvals linked to appointment and remuneration revisions. Another key resolution involved approval for related party transactions with Natural Biogenex. In addition, a remuneration revision for Mr. Shrey Mundra was approved. The company’s voting summary shows that dissent was minimal across items, with only a few hundred votes cast against specific resolutions out of more than 5.3 million votes polled.

Promoter group voting drove near-unanimous results

The filing states that the promoter group holds 5,301,248 shares and voted in favour across all resolutions. For the FY26 financial statements adoption, promoters cast 5,298,987 votes in favour with zero against. Public non-institutional shareholders recorded limited dissent, casting between 184 and 284 votes against certain items. Still, overall approval levels remained above 98% for public non-institutional participants as described in the disclosure. No public institutional shares voted, as per the company’s stated participation summary.

Key voting numbers (AGM resolutions)

The company disclosed resolution-wise voting counts, showing extremely high support.

The company highlighted that one of the resolutions drew only 184 votes against it out of more than 5.3 million votes polled, underlining the scale of support.

Stock snapshot included in the disclosure stream

Alongside the AGM-related disclosures, the provided data stream included a market snapshot showing the stock at 190.95, down 5.24, and a 1-year return of -7.49%. The AGM voting results themselves do not link these figures to any specific market reaction window. Still, the numbers provide context on recent price performance as seen by investors tracking the company’s governance updates and corporate actions.

Next corporate action: EGM on Sep 9, record date Sep 2

Separately, Natural Capsules has also convened an Extraordinary General Meeting (EGM) scheduled for Wednesday, September 09, 2026 at 12:00 PM (IST) through VC/OAVM. The company announced September 2, 2026 as the record date to determine which shareholders are eligible to participate in the EGM. The EGM agenda includes shareholder approval for a preferential issue to the promoter, with the company stating that the fundraising is intended for working capital and capital expansion. The disclosures also note that a corrigendum was issued to revise terms for the preferential issue.

Preferential issue details disclosed

The company’s board approved a preferential issue of 1,12,500 equity shares and 4,50,000 convertible warrants to the promoter group. The EGM notice referenced a preferential issue and warrants totalling Rs.10 crore to its promoter. These corporate action items sit alongside the AGM’s governance approvals and provide investors with a clear sequence of upcoming shareholder decisions. The record date and meeting date disclosures are also relevant for market participants who track eligibility timelines for voting.

Background: earlier shareholder voting on investment limits

The disclosure set also referenced a shareholder process earlier in 2026 relating to investment, loans, guarantees, and securities limits under Section 186. The proposed revised limit mentioned was ₹250 crore, with an e-voting period from February 26, 2026 to March 27, 2026. In the provided voting category table for that process, promoter and promoter group votes polled were 5,280,703 in favour with no votes against, while public non-institutional votes included 15,591 in favour and 201 against. Total votes polled were stated as 5,296,495, equating to about 50.9957% of outstanding shares in one summary line. This context helps investors compare participation levels across different shareholder decisions.

What to watch next

For Natural Capsules, the immediate governance milestone is complete with all AGM resolutions approved and procedural compliance confirmed by the scrutinizer. Attention now shifts to the September 9, 2026 EGM and the preferential issue proposal, with September 2 set as the record date for eligibility. Investors tracking dilution, promoter participation, and the stated use of funds will likely focus on the EGM outcome once the company publishes the voting results and related filings.